My SciELO
Custom servicesServices on Demand
Article
Spanish (pdf)
Article in xml format
Article references
Send this article by e-mailIndicators
Cited by SciELO
Related links
Similars in
SciELO
Share
Permalink
Medicentro Electrónica
On-line version ISSN 1029-3043
Abstract
MIRANDA CHAVIANO, Jorge; TOBOSO ALCANTARA, Manuel V.; LOPEZ RODRIGUEZ, Elvis Fermín and DIAZ GONZALEZ, Marcos Antonio. COVID-19 in cancer patients. Medicentro Electrónica [online]. 2023, vol.27, n.2 Epub Apr 01, 2023. ISSN 1029-3043.
Introduction: the World Health Organization declared COVID-19 as a pandemic on March 11, 2020. A history of cancer is considered a mortality risk factor for multiple diseases; the evolution in patients with neoplastic diseases can be influenced due to superadded conditions such as the case of COVID-19.
Objective: to characterize, from a clinical point of view, cancer patients admitted with COVID-19.
Methods: a descriptive and cross-sectional research was carried out in cancer patients admitted with COVID-19 at "Dr. Celestino Hernández Robau" University Hospital in Villa Clara from January to December 2021. A number of 78 cancer patients with 5 years or less of evolution was included in the study.
Results: male gender and those over 60 years of age predominated. The 39.7% of the patients had lung or laryngeal cancer followed by breast, hemolymphopoietic and colorectal cancers. The 46.2% were in a stable state and 29.5% in palliative care. The 34.6% of them were receiving chemotherapy treatment at the time of admission. Steroids (85.9%), alpha interferon (73.1%) and sodium heparin (55.1%) were the most used drugs.
Conclusions:
lung and laryngeal tumours were the most common malignancy in cancer patients hospitalized with COVID-19, although breast, prostate, and colorectal tumours, in that order, were associated with higher mortality. Patients with disease progression and those receiving chemotherapy were more likely to die.
Keywords : patient-centered care; neoplasms; laryngeal neoplasms; lung neoplasms; covid-19.
